Celldex Therapeutics | CLDX - EPS Earnings Per Share


Celldex Therapeutics reported $-0.96 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 -0.96 -1.07 -1.01 Nov/05
FY2026Q2 Jun/2026 -0.94 -1.06 -0.85 Aug/06
FY2026Q1 Mar/2026 -1.18 -1.19 -0.71 May/07
FY2025Q4 Dec/2025 -1.22 -1 -0.71 Feb/25
FY2025Q3 Sep/2025 -1.01 -0.9 -0.64 Nov/10




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Agenus USD 1.02 1.32 Mar/2026
Amgen USD 6.45 0.16 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Celldex Therapeutics USD -0.96 0.02 Sep/2026
Glaxosmithkline GBP 0.76 0.14 Sep/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Northwest Biotherapeutics USD -0.01 0 Mar/2026
Pfizer USD 0.87 0.1 Sep/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Roche Holding CHF 10.98 2.61 Jun/2026